Cargando…
Altered glycosylation of glycodelin in endometrial carcinoma
Glycodelin is a major glycoprotein expressed in reproductive tissues, like secretory and decidualized endometrium. It has several reproduction related functions that are dependent on specific glycosylation, but it has also been found to drive differentiation of endometrial carcinoma cells toward a l...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312397/ https://www.ncbi.nlm.nih.gov/pubmed/32205858 http://dx.doi.org/10.1038/s41374-020-0411-x |
_version_ | 1783549718710714368 |
---|---|
author | Hautala, Laura C. Pang, Poh-Choo Antonopoulos, Aristotelis Pasanen, Annukka Lee, Cheuk-Lun Chiu, Philip C. N. Yeung, William S. B. Loukovaara, Mikko Bützow, Ralf Haslam, Stuart M. Dell, Anne Koistinen, Hannu |
author_facet | Hautala, Laura C. Pang, Poh-Choo Antonopoulos, Aristotelis Pasanen, Annukka Lee, Cheuk-Lun Chiu, Philip C. N. Yeung, William S. B. Loukovaara, Mikko Bützow, Ralf Haslam, Stuart M. Dell, Anne Koistinen, Hannu |
author_sort | Hautala, Laura C. |
collection | PubMed |
description | Glycodelin is a major glycoprotein expressed in reproductive tissues, like secretory and decidualized endometrium. It has several reproduction related functions that are dependent on specific glycosylation, but it has also been found to drive differentiation of endometrial carcinoma cells toward a less malignant phenotype. Here we aimed to elucidate whether the glycosylation and function of glycodelin is altered in endometrial carcinoma as compared with a normal endometrium. We carried out glycan structure analysis of glycodelin expressed in HEC-1B human endometrial carcinoma cells (HEC-1B Gd) by mass spectrometry glycomics strategies. Glycans of HEC-1B Gd were found to comprise a typical mixture of high-mannose, hybrid, and complex-type N-glycans, often containing undecorated LacNAc (Galβ1–4GlcNAc) antennae. However, several differences, as compared with previously reported glycan structures of normal human decidualized endometrium-derived glycodelin isoform, glycodelin-A (GdA), were also found. These included a lower level of sialylation and more abundant poly-LacNAc antennae, some of which are fucosylated. This allowed us to select lectins that showed different binding to these classes of glycodelin. Despite the differences in glycosylation between HEC-1B Gd and GdA, both showed similar inhibitory activity on trophoblast cell invasion and peripheral blood mononuclear cell proliferation. For the detection of cancer associated glycodelin, we established a novel in situ proximity-ligation based histochemical staining method using a specific glycodelin antibody and UEAI lectin. We found that the UEAI reactive glycodelin was abundant in endometrial carcinoma, but virtually absent in normal endometrial tissue even when glycodelin was strongly expressed. In conclusion, we established a histochemical staining method for the detection of endometrial carcinoma-associated glycodelin and showed that this specific glycodelin is exclusively expressed in cancer, not in normal endometrium. Similar methods can be used for studies of other glycoproteins. |
format | Online Article Text |
id | pubmed-7312397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-73123972020-06-26 Altered glycosylation of glycodelin in endometrial carcinoma Hautala, Laura C. Pang, Poh-Choo Antonopoulos, Aristotelis Pasanen, Annukka Lee, Cheuk-Lun Chiu, Philip C. N. Yeung, William S. B. Loukovaara, Mikko Bützow, Ralf Haslam, Stuart M. Dell, Anne Koistinen, Hannu Lab Invest Technical Report Glycodelin is a major glycoprotein expressed in reproductive tissues, like secretory and decidualized endometrium. It has several reproduction related functions that are dependent on specific glycosylation, but it has also been found to drive differentiation of endometrial carcinoma cells toward a less malignant phenotype. Here we aimed to elucidate whether the glycosylation and function of glycodelin is altered in endometrial carcinoma as compared with a normal endometrium. We carried out glycan structure analysis of glycodelin expressed in HEC-1B human endometrial carcinoma cells (HEC-1B Gd) by mass spectrometry glycomics strategies. Glycans of HEC-1B Gd were found to comprise a typical mixture of high-mannose, hybrid, and complex-type N-glycans, often containing undecorated LacNAc (Galβ1–4GlcNAc) antennae. However, several differences, as compared with previously reported glycan structures of normal human decidualized endometrium-derived glycodelin isoform, glycodelin-A (GdA), were also found. These included a lower level of sialylation and more abundant poly-LacNAc antennae, some of which are fucosylated. This allowed us to select lectins that showed different binding to these classes of glycodelin. Despite the differences in glycosylation between HEC-1B Gd and GdA, both showed similar inhibitory activity on trophoblast cell invasion and peripheral blood mononuclear cell proliferation. For the detection of cancer associated glycodelin, we established a novel in situ proximity-ligation based histochemical staining method using a specific glycodelin antibody and UEAI lectin. We found that the UEAI reactive glycodelin was abundant in endometrial carcinoma, but virtually absent in normal endometrial tissue even when glycodelin was strongly expressed. In conclusion, we established a histochemical staining method for the detection of endometrial carcinoma-associated glycodelin and showed that this specific glycodelin is exclusively expressed in cancer, not in normal endometrium. Similar methods can be used for studies of other glycoproteins. Nature Publishing Group US 2020-03-23 2020 /pmc/articles/PMC7312397/ /pubmed/32205858 http://dx.doi.org/10.1038/s41374-020-0411-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Technical Report Hautala, Laura C. Pang, Poh-Choo Antonopoulos, Aristotelis Pasanen, Annukka Lee, Cheuk-Lun Chiu, Philip C. N. Yeung, William S. B. Loukovaara, Mikko Bützow, Ralf Haslam, Stuart M. Dell, Anne Koistinen, Hannu Altered glycosylation of glycodelin in endometrial carcinoma |
title | Altered glycosylation of glycodelin in endometrial carcinoma |
title_full | Altered glycosylation of glycodelin in endometrial carcinoma |
title_fullStr | Altered glycosylation of glycodelin in endometrial carcinoma |
title_full_unstemmed | Altered glycosylation of glycodelin in endometrial carcinoma |
title_short | Altered glycosylation of glycodelin in endometrial carcinoma |
title_sort | altered glycosylation of glycodelin in endometrial carcinoma |
topic | Technical Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312397/ https://www.ncbi.nlm.nih.gov/pubmed/32205858 http://dx.doi.org/10.1038/s41374-020-0411-x |
work_keys_str_mv | AT hautalalaurac alteredglycosylationofglycodelininendometrialcarcinoma AT pangpohchoo alteredglycosylationofglycodelininendometrialcarcinoma AT antonopoulosaristotelis alteredglycosylationofglycodelininendometrialcarcinoma AT pasanenannukka alteredglycosylationofglycodelininendometrialcarcinoma AT leecheuklun alteredglycosylationofglycodelininendometrialcarcinoma AT chiuphilipcn alteredglycosylationofglycodelininendometrialcarcinoma AT yeungwilliamsb alteredglycosylationofglycodelininendometrialcarcinoma AT loukovaaramikko alteredglycosylationofglycodelininendometrialcarcinoma AT butzowralf alteredglycosylationofglycodelininendometrialcarcinoma AT haslamstuartm alteredglycosylationofglycodelininendometrialcarcinoma AT dellanne alteredglycosylationofglycodelininendometrialcarcinoma AT koistinenhannu alteredglycosylationofglycodelininendometrialcarcinoma |